+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atrophic Scar Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 227 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5925045
The global atrophic scar treatment market is expected to experience significant growth by the end of 2031. Over the forecast period from 2024 to 2031, the market is anticipated to grow at a moderate yet positive compound annual growth rate (CAGR). The overall outlook for atrophic scar treatment is optimistic.

Factors Driving Market Growth

The atrophic scar treatment market is poised for growth, with multiple factors contributing to its expansion. Key drivers include:

  • A rising prevalence of skin disorders.
  • An increasing demand for advanced treatment alternatives and product innovations.
  • A growing global need for age-defying treatment therapies.
  • Surging awareness and preference for personal care.
  • Improving economies in emerging countries.
  • Increasing healthcare expenditure by both consumers and governments.
  • A favorable reimbursement scenario in certain developed countries.
  • International exchange of treatment ideas, widening growth opportunities.
  • A growing consumer demand for shorter treatment periods that offer quick results.

Preferred Types of Treatment

The market is segmented by product type into four categories: topical scar products, laser products, surface treatment, and injectable products. Among these, topical scar products will continue to dominate the market, maintaining over 50% of the market share by value, despite a slight decline by 2031. Laser therapy is gaining popularity among affluent consumers, although it is expected to witness a decline in market share. Surface treatment is forecasted to capture over 20% of the total market value by 2031, followed by injectables. Notably, topical treatments are gradually losing popularity among wealthier consumers, while lasers and injectables are gaining traction. However, the relatively higher cost of the latter two treatments will remain a constraint throughout the forecast period.

Regional Outlook

North America is anticipated to remain the dominant regional market, with Asia-Pacific (APAC) following closely as the second-largest market. Within APAC, China, India, and Japan will be key regions driving market growth. While the Middle East and Africa (MEA) show stable growth potential, Latin America is expected to experience the fastest growth during the forecast period. Brazil, in particular, will lead the way in Latin America due to the increasing popularity of cosmetic interventions.

Atrophic Scar Treatment Market Segmentation

The worldwide atrophic scar treatment market has been categorized based on product type and end-user. This comprehensive report thoroughly assesses each segment and sub-segment, offering insights into the historical, current, and projected conditions within the global atrophic scar treatment market over the evaluation period.

Product Type

  • Topical
  • Gels
  • Creams
  • Oils
  • Laser
  • CO2 Lasers
  • Pulsed Dye Laser
  • Surface treatment
  • Injectable

Distribution Channel

  • Hospitals
  • Clinics
  • Pharmacies and drug stores
  • E-Commerce

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Atrophic Scar Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Atrophic Scar Treatment Market Outlook, 2018 - 2031
3.1. Global Atrophic Scar Treatment Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Topical
3.1.1.1.1. Gels
3.1.1.1.2. Creams
3.1.1.1.3. Oils
3.1.1.2. Laser
3.1.1.2.1. CO2 Lasers
3.1.1.2.2. Pulsed Dye Laser
3.1.1.3. Surface treatment
3.1.1.4. Injectable
3.2. Global Atrophic Scar Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Clinics
3.2.1.3. Pharmacies and drug stores
3.2.1.4. E-Commerce
3.3. Global Atrophic Scar Treatment Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Atrophic Scar Treatment Market Outlook, 2018 - 2031
4.1. North America Atrophic Scar Treatment Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Topical
4.1.1.1.1. Gels
4.1.1.1.2. Creams
4.1.1.1.3. Oils
4.1.1.2. Laser
4.1.1.2.1. CO2 Lasers
4.1.1.2.2. Pulsed Dye Laser
4.1.1.3. Surface treatment
4.1.1.4. Injectable
4.2. North America Atrophic Scar Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Clinics
4.2.1.3. Pharmacies and drug stores
4.2.1.4. E-Commerce
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Atrophic Scar Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
4.3.1.2. U.S. Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
4.3.1.3. Canada Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
4.3.1.4. Canada Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Atrophic Scar Treatment Market Outlook, 2018 - 2031
5.1. Europe Atrophic Scar Treatment Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Topical
5.1.1.1.1. Gels
5.1.1.1.2. Creams
5.1.1.1.3. Oils
5.1.1.2. Laser
5.1.1.2.1. CO2 Lasers
5.1.1.2.2. Pulsed Dye Laser
5.1.1.3. Surface treatment
5.1.1.4. Injectable
5.2. Europe Atrophic Scar Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Clinics
5.2.1.3. Pharmacies and drug stores
5.2.1.4. E-Commerce
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Atrophic Scar Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
5.3.1.2. Germany Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.3. U.K. Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
5.3.1.4. U.K. Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.5. France Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
5.3.1.6. France Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.7. Italy Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
5.3.1.8. Italy Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.9. Turkey Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
5.3.1.10. Turkey Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.11. Russia Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
5.3.1.12. Russia Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.1.13. Rest of Europe Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
5.3.1.14. Rest of Europe Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Atrophic Scar Treatment Market Outlook, 2018 - 2031
6.1. Asia Pacific Atrophic Scar Treatment Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Topical
6.1.1.1.1. Gels
6.1.1.1.2. Creams
6.1.1.1.3. Oils
6.1.1.2. Laser
6.1.1.2.1. CO2 Lasers
6.1.1.2.2. Pulsed Dye Laser
6.1.1.3. Surface treatment
6.1.1.4. Injectable
6.1.1.5. Thioxanthenes
6.1.1.6. Miscellaneous Antipsychotic Agents
6.2. Asia Pacific Atrophic Scar Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Clinics
6.2.1.3. Pharmacies and drug stores
6.2.1.4. E-Commerce
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Atrophic Scar Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
6.3.1.2. China Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.3. Japan Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
6.3.1.4. Japan Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.5. South Korea Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
6.3.1.6. South Korea Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.7. India Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
6.3.1.8. India Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.9. Southeast Asia Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
6.3.1.10. Southeast Asia Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Atrophic Scar Treatment Market Outlook, 2018 - 2031
7.1. Latin America Atrophic Scar Treatment Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Topical
7.1.1.1.1. Gels
7.1.1.1.2. Creams
7.1.1.1.3. Oils
7.1.1.2. Laser
7.1.1.2.1. CO2 Lasers
7.1.1.2.2. Pulsed Dye Laser
7.1.1.3. Surface treatment
7.1.1.4. Injectable
7.2. Latin America Atrophic Scar Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Clinics
7.2.1.3. Pharmacies and drug stores
7.2.1.4. E-Commerce
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Atrophic Scar Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
7.3.1.2. Brazil Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.3.1.3. Mexico Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
7.3.1.4. Mexico Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.3.1.5. Argentina Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
7.3.1.6. Argentina Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.3.1.7. Rest of Latin America Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
7.3.1.8. Rest of Latin America Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Atrophic Scar Treatment Market Outlook, 2018 - 2031
8.1. Middle East & Africa Atrophic Scar Treatment Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Topical
8.1.1.1.1. Gels
8.1.1.1.2. Creams
8.1.1.1.3. Oils
8.1.1.2. Laser
8.1.1.2.1. CO2 Lasers
8.1.1.2.2. Pulsed Dye Laser
8.1.1.3. Surface treatment
8.1.1.4. Injectable
8.2. Middle East & Africa Atrophic Scar Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Clinics
8.2.1.3. Pharmacies and drug stores
8.2.1.4. E-Commerce
8.3. Middle East & Africa Atrophic Scar Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
8.3.1.2. GCC Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.1.3. South Africa Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
8.3.1.4. South Africa Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.1.5. Egypt Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
8.3.1.6. Egypt Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.1.7. Nigeria Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
8.3.1.8. Nigeria Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Atrophic Scar Treatment Market by Product Type, Value (US$ Mn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Atrophic Scar Treatment Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs by Distribution Channel Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Merz Inc
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Enaltus LLC
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Oculus Innovative Sciences Inc.
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. CCA Industries Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Cynosure Inc.
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Lumenis
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Syneron Medical Ltd.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. NutraMarks Inc
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Mölnlycke Health Care
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Pacific World Corporation
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Valeant Pharmaceuticals International Inc
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Shanghai Fosun Pharmaceuticals Ltd (ACAlma Lasers)
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Beijing Toplaser Technology Co. Ltd
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Sonoma Pharmaceuticals Inc.
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Merz Inc.
  • Enaltus LLC
  • Oculus Innovative Sciences Inc.
  • CCA Industries Inc.
  • Cynosure Inc.
  • LUMENIS
  • Syneron Medical Ltd.
  • NutraMarks Inc.
  • Mölnlycke Health Care
  • Pacific World Corporation
  • Valeant Pharmaceuticals International Inc
  • Shanghai Fosun Pharmaceuticals Ltd(ACAlma Lasers)
  • Beijing Toplaser Technology Co. Ltd
  • Sonoma Pharmaceuticals Inc.

Methodology

Loading
LOADING...